NYSE:THC - Tenet Healthcare Stock Price, News, Headlines & Rumors Sign in or create an account to add this stock to your watchlist. Get Started $33.09 -0.09 (-0.27 %) (As of 08/16/2018 08:00 AM ET)Previous Close$33.18Today's Range$32.66 - $33.5452-Week Range$12.25 - $39.74Volume2.18 million shsAverage Volume2.11 million shsMarket Capitalization$3.31 billionP/E Ratio40.85Dividend YieldN/ABeta1.05 Company ProfileAnalyst RatingsChartEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Tenet Healthcare Corporation operates as a diversified healthcare services company. It operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The company's general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. It also provides intensive and critical care, and coronary care units; physical therapy, orthopedic, oncology, and outpatient services; tertiary care services, including cardiothoracic surgery, neonatal intensive care, and neurosciences; quaternary care in heart, liver, kidney, and bone marrow transplants areas; tertiary and quaternary pediatric, and burn services; and limb-salvaging vascular procedures, acute level 1 trauma services, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, and telemedicine access for various medical specialties. In addition, the company operates ambulatory surgery and urgent care centers, imaging centers, and surgical hospitals, as well as Aspen's hospitals and clinics; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, as well as value-based care solutions to healthcare systems, individual hospitals, physician practices, self-insured organizations, health plans, and other entities. Further, it offers accounts receivable and health information management, and revenue integrity and patient financial services; patient communications and engagement services; and clinical integration, financial risk management, and population health management services. As of December 31, 2017, the company operated 76 hospitals, 20 surgical hospitals, and approximately 470 outpatient centers, as well as 247 ambulatory surgery, 34 urgent care, and 23 imaging centers in the United States; and 9 private hospitals and clinics in the United Kingdom. The company was founded in 1967 and is headquartered in Dallas, Texas. Receive THC News and Ratings via Email Sign-up to receive the latest news and ratings for THC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry General medical & surgical hospitals Sub-IndustryHealth Care Facilities SectorMedical SymbolNYSE:THC CUSIP88033G40 Webwww.tenethealth.com Phone469-893-2200 Debt Debt-to-Equity Ratio24.66 Current Ratio1.08 Quick Ratio1.01 Price-To-Earnings Trailing P/E Ratio40.85 Forward P/E Ratio19.46 P/E Growth1.46 Sales & Book Value Annual Sales$19.18 billion Price / Sales0.18 Cash Flow$10.1193 per share Price / Cash3.27 Book Value$5.34 per share Price / Book6.20 Profitability EPS (Most Recent Fiscal Year)$0.81 Net Income$-704,000,000.00 Net Margins-2.51% Return on Equity38.91% Return on Assets1.02% Miscellaneous Employees126,000 Outstanding Shares102,400,000Market Cap$3.31 billion Tenet Healthcare (NYSE:THC) Frequently Asked Questions What is Tenet Healthcare's stock symbol? Tenet Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "THC." How were Tenet Healthcare's earnings last quarter? Tenet Healthcare Corp (NYSE:THC) announced its quarterly earnings results on Monday, August, 6th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.25 by $0.24. The company had revenue of $4.51 billion for the quarter, compared to the consensus estimate of $4.57 billion. Tenet Healthcare had a positive return on equity of 38.91% and a negative net margin of 2.51%. Tenet Healthcare's revenue was down 6.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.17) EPS. View Tenet Healthcare's Earnings History. When is Tenet Healthcare's next earnings date? Tenet Healthcare is scheduled to release their next quarterly earnings announcement on Friday, October, 26th 2018. View Earnings Estimates for Tenet Healthcare. What guidance has Tenet Healthcare issued on next quarter's earnings? Tenet Healthcare updated its FY18 earnings guidance on Monday, August, 6th. The company provided earnings per share guidance of $1.54-1.88 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.56. The company issued revenue guidance of $17.9-18.3 billion, compared to the consensus revenue estimate of $18.15 billion.Tenet Healthcare also updated its Q3 guidance to $0.10-0.24 EPS. What price target have analysts set for THC? 17 brokers have issued 12 month price targets for Tenet Healthcare's stock. Their forecasts range from $15.00 to $44.00. On average, they expect Tenet Healthcare's share price to reach $29.8750 in the next twelve months. This suggests that the stock has a possible downside of 9.7%. View Analyst Price Targets for Tenet Healthcare. What is the consensus analysts' recommendation for Tenet Healthcare? 17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tenet Healthcare in the last year. There are currently 2 sell ratings, 9 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Tenet Healthcare. Who are some of Tenet Healthcare's key competitors? Some companies that are related to Tenet Healthcare include Universal Health Services, Inc. Class B (UHS), LifePoint Health (LPNT), Surgery Partners (SGRY), Community Health Systems (CYH) and Quorum Health (QHC). Who are Tenet Healthcare's key executives? Tenet Healthcare's management team includes the folowing people: Mr. Ronald A. Rittenmeyer, Exec. Chairman & CEO (Age 71)Mr. Daniel J. Cancelmi, Chief Financial Officer (Age 55)Ms. Audrey T. Andrews, Sr. VP & Gen. Counsel (Age 51)Mr. Keith B. Pitts, Vice Chairman (Age 60)Mr. Jason Eric Evans, Pres of Hospital Operations (Age 41) Has Tenet Healthcare been receiving favorable news coverage? Media stories about THC stock have trended somewhat positive recently, Accern Sentiment reports. The research firm identifies positive and negative press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Tenet Healthcare earned a media and rumor sentiment score of 0.12 on Accern's scale. They also gave media coverage about the company an impact score of 46.64 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near term. View Recent Headlines for Tenet Healthcare. Who are Tenet Healthcare's major shareholders? Tenet Healthcare's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Partner Fund Management L.P. (4.24%), Dimensional Fund Advisors LP (2.30%), Scopia Capital Management LP (1.81%), Letko Brosseau & Associates Inc. (1.80%), Morgan Stanley (1.14%) and Columbus Circle Investors (1.06%). Company insiders that own Tenet Healthcare stock include Ashish Dave, George Fredrick Smitherman, Peter M Wilver and Ronald A Rittenmeyer. View Institutional Ownership Trends for Tenet Healthcare. Which major investors are selling Tenet Healthcare stock? THC stock was sold by a variety of institutional investors in the last quarter, including Orbimed Advisors LLC, Millennium Management LLC, Sector Gamma AS, FMR LLC, California Public Employees Retirement System, Columbus Circle Investors, Scopia Capital Management LP and Private Management Group Inc.. Company insiders that have sold Tenet Healthcare company stock in the last year include Ashish Dave and George Fredrick Smitherman. View Insider Buying and Selling for Tenet Healthcare. Which major investors are buying Tenet Healthcare stock? THC stock was bought by a variety of institutional investors in the last quarter, including Partner Fund Management L.P., Morgan Stanley, Hood River Capital Management LLC, Castleark Management LLC, First Trust Advisors LP, Convergence Investment Partners LLC, Chicago Equity Partners LLC and Schwab Charles Investment Management Inc.. Company insiders that have bought Tenet Healthcare stock in the last two years include George Fredrick Smitherman, Peter M Wilver and Ronald A Rittenmeyer. View Insider Buying and Selling for Tenet Healthcare. How do I buy shares of Tenet Healthcare? Shares of THC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Tenet Healthcare's stock price today? One share of THC stock can currently be purchased for approximately $33.09. How big of a company is Tenet Healthcare? Tenet Healthcare has a market capitalization of $3.31 billion and generates $19.18 billion in revenue each year. The company earns $-704,000,000.00 in net income (profit) each year or $0.81 on an earnings per share basis. Tenet Healthcare employs 126,000 workers across the globe. How can I contact Tenet Healthcare? Tenet Healthcare's mailing address is 1445 ROSS AVENUE SUITE 1400, DALLAS TX, 75202. The company can be reached via phone at 469-893-2200 or via email at [email protected] MarketBeat Community Rating for Tenet Healthcare (NYSE THC)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 437 (Vote Outperform)Underperform Votes: 572 (Vote Underperform)Total Votes: 1,009MarketBeat's community ratings are surveys of what our community members think about Tenet Healthcare and other stocks. Vote "Outperform" if you believe THC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe THC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 8/16/2018 by MarketBeat.com StaffFeatured Article: Asset Allocation Models, Which is Right For You?